FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy

Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates

(2009) Steven C. Zammit et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Inhibition of Protein Kinase C–β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy

(2009) Kim A. Connelly et al.   Circulation-Heart Failure

Left ventricular anatomical and functional changes with ageing in type 2 diabetic adults

(2009) A. Stefanidis et al.   European Journal of Echocardiography

Understanding the ‘epidemic of heart failure’: a systematic review of trends in determinants of heart failure

(2009) Farid Najafi et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction

(2008) Arintaya Phrommintikul et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Heart Disease and Stroke Statistics—2009 Update

(2008) et al.   CIRCULATION